๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans

Uy Ear

Stock Analyst at Mizuho Securities

(4.06)
# 1,719
Out of 5,189 analysts
616
Total ratings
43.3%
Success rate
6.1%
Average return

Stocks Rated by Uy Ear

Acadia Pharmaceuticals
Sep 15, 2026
Rated: Hold
Price Target: n/a
Current: $17.11
Upside: -
Arcutis Biotherapeutics
Sep 15, 2026
Rated: Hold
Price Target: n/a
Current: $26.36
Upside: -
Evolus
Sep 15, 2026
Rated: Hold
Price Target: n/a
Current: $6.52
Upside: -
IN8bio
Sep 15, 2026
Rated: Hold
Price Target: n/a
Current: $0.758
Upside: -
MBX Biosciences
Sep 15, 2026
Rated: Hold
Price Target: n/a
Current: $49.55
Upside: -
Q32 Bio
Sep 15, 2026
Rated: Hold
Price Target: n/a
Current: $8.34
Upside: -
uniQure
Sep 15, 2026
Rated: Hold
Price Target: n/a
Current: $19.35
Upside: -
Relmada Therapeutics
Sep 15, 2026
Rated: Hold
Price Target: n/a
Current: $2.62
Upside: -
Cartesian Therapeutics
Sep 15, 2026
Rated: Hold
Price Target: n/a
Current: $6.14
Upside: -
Sol-Gel Technologies
Sep 15, 2026
Rated: Hold
Price Target: n/a
Current: $55.17
Upside: -
Rated: Hold
Price Target: n/a
Current: $13.33
Upside: -
Rated: Hold
Price Target: n/a
Current: $20.73
Upside: -
Reiterated: Buy
Price Target: $65
Current: $44.94
Upside: +44.64%
Reiterated: Hold
Price Target: $146 → $175
Current: $150.57
Upside: +16.23%
Rated: Hold
Price Target: n/a
Current: $0.7679
Upside: n/a
Rated: Hold
Price Target: n/a
Current: $0.9361
Upside: n/a
Initiated Coverage: Hold
Price Target: $14
Current: $4.70
Upside: n/a